Progyny (PGNY) Revenue (2018 - 2026)

Progyny (PGNY) has reported Revenue for 9 consecutive years, with $350.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 5.3% year-over-year to $350.5 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 5.54% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 10.4% from the prior year.
• Revenue was $350.5 million for Q2 2026 at Progyny, up from $328.5 million in the prior quarter.
• Over five years, Revenue peaked at $350.5 million in Q2 2026 and troughed at $172.2 million in Q1 2022.
• A 5-year average of $278.4 million and a median of $283.8 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 68.03% in 2022 and increased 1.38% in 2026, its largest moves.
• Over 5 years, Revenue stood at $214.3 million in 2022, then rose by 25.95% to $269.9 million in 2023, then grew by 10.55% to $298.4 million in 2024, then climbed by 6.69% to $318.4 million in 2025, then climbed by 10.08% to $350.5 million in 2026.
• The last three Revenue figures came in at $350.5 million (Q2 2026), $328.5 million (Q1 2026), and $318.4 million (Q4 2025), per Business Quant data.